Physician profile
Deandra Moore
NPI 1659633717
$1,173.98
in general payments reported to CMS, 2019-2025
20 companies · $42.15 in 2025
The $42.15 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $206 · 2023: $531 · 2024: $201 · 2025: $42.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $270.53 | 2021-2025 | |
| Glaxosmithkline, LLC. | $146.39 | 2022-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.92 | 2021-2024 | Stiolto Respimat |
| Dexcom, INC. | $109.36 | 2023 | Dexcom G7 Gss (161) |
| Bayer Healthcare Pharmaceuticals INC. | $80.05 | 2022-2023 | |
| Lilly USA, LLC | $66.74 | 2021-2024 | |
| Pfizer INC. | $51.46 | 2021-2022 | |
| Novo Nordisk INC | $51.39 | 2022-2024 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $40.14 | 2023-2024 | Cologuard Collection Kit |
| Eisai INC. | $31.67 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.96 | 2023 | Xifaxan |
| Phathom Pharmaceuticals, INC. | $24.18 | 2024 | Voquezna |
| Vertex Pharmaceuticals Incorporated | $21.68 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.18 | 2022 | |
| Astellas Pharma US INC | $20.03 | 2024 | Veozah |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $18.23 | 2022 | |
| Gilead Sciences, INC. | $17.01 | 2021 | |
| Shield Therapeutics INC | $16.41 | 2023 | Accrufer |
| Currax Pharmaceuticals LLC | $15.14 | 2023 | Contrave |
| Almatica Pharma LLC | $13.51 | 2023 | Sertraline Hcl, Loreev Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deandra Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.